Mitochondrial DNA depletion syndrome, myopathic form

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:254875OMIM:609560G71.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mitochondrial DNA depletion syndrome, myopathic form (also known as MDS, myopathic form or mitochondrial DNA depletion syndrome 2, myopathic type) is a rare, severe genetic disorder characterized by a marked reduction in mitochondrial DNA (mtDNA) copy number primarily affecting skeletal muscle. This leads to impaired mitochondrial respiratory chain function and progressive muscle weakness. The condition predominantly affects the muscular system, though other organs may also be involved to varying degrees. It is caused by pathogenic variants in genes essential for mitochondrial DNA maintenance, most commonly TK2 (thymidine kinase 2), which encodes an enzyme critical for mitochondrial nucleotide metabolism. The myopathic form typically presents in infancy or early childhood with progressive muscle weakness (myopathy), hypotonia (reduced muscle tone), difficulty feeding, and motor regression — meaning children may lose previously acquired motor skills such as walking or sitting. Affected individuals often develop respiratory insufficiency due to weakness of the breathing muscles, which can be life-threatening. Elevated serum creatine kinase levels and ragged red fibers on muscle biopsy are characteristic findings. Some patients may also develop mild involvement of other organs, but the predominant clinical picture is skeletal muscle disease. Currently, there is no definitive cure for this condition. Management is primarily supportive and includes respiratory support (including mechanical ventilation when needed), physical therapy, nutritional support, and monitoring for complications. Deoxynucleoside substrate therapy (specifically oral deoxynucleosides such as deoxythymidine and deoxycytidine) has shown promise in clinical studies for TK2-related myopathic MDS, with some patients demonstrating stabilization or improvement in motor and respiratory function. Early diagnosis and intervention are important for optimizing outcomes.

Also known as:

Clinical phenotype terms— hover any for plain English:

Motor deteriorationHP:0002333Difficulty standingHP:0003698
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mitochondrial DNA depletion syndrome, myopathic form.

View clinical trials →

No actively recruiting trials found for Mitochondrial DNA depletion syndrome, myopathic form at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mitochondrial DNA depletion syndrome, myopathic form community →

No specialists are currently listed for Mitochondrial DNA depletion syndrome, myopathic form.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mitochondrial DNA depletion syndrome, myopathic form.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mitochondrial DNA depletion syndrome, myopathic formForum →

No community posts yet. Be the first to share your experience with Mitochondrial DNA depletion syndrome, myopathic form.

Start the conversation →

Latest news about Mitochondrial DNA depletion syndrome, myopathic form

No recent news articles for Mitochondrial DNA depletion syndrome, myopathic form.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mitochondrial DNA depletion syndrome, myopathic form

What is Mitochondrial DNA depletion syndrome, myopathic form?

Mitochondrial DNA depletion syndrome, myopathic form (also known as MDS, myopathic form or mitochondrial DNA depletion syndrome 2, myopathic type) is a rare, severe genetic disorder characterized by a marked reduction in mitochondrial DNA (mtDNA) copy number primarily affecting skeletal muscle. This leads to impaired mitochondrial respiratory chain function and progressive muscle weakness. The condition predominantly affects the muscular system, though other organs may also be involved to varying degrees. It is caused by pathogenic variants in genes essential for mitochondrial DNA maintenance,

How is Mitochondrial DNA depletion syndrome, myopathic form inherited?

Mitochondrial DNA depletion syndrome, myopathic form follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mitochondrial DNA depletion syndrome, myopathic form typically begin?

Typical onset of Mitochondrial DNA depletion syndrome, myopathic form is infantile. Age of onset can vary across affected individuals.